European Urology

Editorial Board

19 November 2009 | page i

Contents

19 November 2009 | pages v - viii

  Biopsy Schemes with the Fewest Cores for Detecting 95% of the Prostate Cancers Detected by a 24-Core Biopsy

Vincenzo Scattoni, Marco Raber, Firas Abdollah, Marco Roscigno, Federico Dehò, Diego Angiolilli, Carmen Maccagnano, Andrea Gallina, Umberto Capitanio, Massimo Freschi, Claudio Doglioni, Patrizio Rigatti, Francesco Montorsi.

19 August 2009 | pages 1 - 8

The Ultimate Prostate Cancer Biopsy Decision Support Tool

Michael W. Kattan, J. Stephen Jones.

26 August 2009 | pages 9 - 10

Reply from Authors re: Michael W. Kattan, J. Stephen Jones. The Ultimate Prostate Cancer Biopsy Decision Support Tool. Eur Urol 2010;57:9–10

Vincenzo Scattoni.

4 September 2009 | pages 10 - 11

  Predicting Recurrence and Progression of Noninvasive Papillary Bladder Cancer at Initial Presentation Based on Quantitative Gene Expression Profiles

Marc Birkhahn, Anirban P. Mitra, Anthony J. Williams, Gitte Lam, Wei Ye, Ram H. Datar, Marija Balic, Susan Groshen, Kenneth E. Steven, Richard J. Cote.

9 September 2009 | pages 12 - 20

In Search of the Perfect Crystal Ball for Ta Urothelial Cancer

Joseph L. Chin.

8 September 2009 | pages 21 - 22

Reply from Authors re: Joseph L. Chin. In Search of the Perfect Crystal Ball for Ta Urothelial Cancer. Eur Urol 2010;57:21–2

Anirban P. Mitra, Marc Birkhahn, Richard J. Cote.

4 October 2009 | pages 23 - 24

  Bacillus Calmette-Guérin Is Superior to a Combination of Epirubicin and Interferon-α2b in the Intravesical Treatment of Patients with Stage T1 Urinary Bladder Cancer. A Prospective, Randomized, Nordic Study

Miloš Duchek, Robert Johansson, Staffan Jahnson, Oddvar Mestad, Pekka Hellström, Sverker Hellsten, Per-Uno Malmström, Members of the Urothelial Cancer Group of the Nordic Association of Urology.

6 October 2009 | pages 25 - 31

What is the Optimal Treatment Strategy for T1 Bladder Tumors?

Marko Babjuk.

15 October 2009 | pages 32 - 34